 |
|
Strategies to Prevent Suicide—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: Drs Tondo and Baldessarini comment on our point that suicidal behavior in conditions such as bipolar disorder and schizophrenia may respond specifically to lithium and clozapine, respectively, by raising the interesting question as to why randomized controlled trials have not shown that antidepressants reduce rates of suicidal behavior in major depressive disorder. Part of the reason may be that clinical trials in major depression have almost uniformly not been designed to detect effects on suicidal behavior, and that most trials excluded acutely suicidal patients. Studies specifically designed to address this question are needed because use of antidepressants in major depression has emerged as the centerpiece of most suicide prevention efforts.
Drs Knox and Caine fly to the defense of the US Air Force Suicide Prevention Program as being much more than a gatekeeper program. We do not disagree but point out that reports from this admirable program have . . . [Full Text of this Article]
J. John Mann, MD
jjm@columbia.edu
Columbia University
Division of Neuroscience
New York, NY
RELATED ARTICLES
Strategies to Prevent Suicide
Leonardo Tondo and Ross J. Baldessarini
JAMA. 2006;295(13):1515.
EXTRACT
| FULL TEXT
Strategies to Prevent Suicide
Kerry L. Knox and Eric D. Caine
JAMA. 2006;295(13):1515-1516.
EXTRACT
| FULL TEXT
Suicide Prevention Strategies: A Systematic Review
J. John Mann, Alan Apter, Jose Bertolote, Annette Beautrais, Dianne Currier, Ann Haas, Ulrich Hegerl, Jouko Lonnqvist, Kevin Malone, Andrej Marusic, Lars Mehlum, George Patton, Michael Phillips, Wolfgang Rutz, Zoltan Rihmer, Armin Schmidtke, David Shaffer, Morton Silverman, Yoshitomo Takahashi, Airi Varnik, Danuta Wasserman, Paul Yip, and Herbert Hendin
JAMA. 2005;294(16):2064-2074.
ABSTRACT
| FULL TEXT
|
